Top Purchase Related
Home
>
Node
>
Subnode

Emtriva (emtricitabine, FTC)

Kronborg, G.

Ugeskrift for Laeger 166(49): 4458-4459

2004

ISSN/ISBN: 0041-5782
PMID: 15626092
Document Number: 573387

Document emailed within 1 workday
Secure & encrypted payments

2013: Cobicistat + elvitegravir + emtricitabine + tenofovir. Two new drugs, but no progress Prescrire international 22(142): 233-235
Daneshtalab, M. 2000: Emtricitabine (Emory University/Glaxo Wellcome/Triangle Pharmaceuticals) Idrugs: the Investigational Drugs Journal 3(8): 940-952
Arrivé, E.; Chaix, M-Laure.; Nerrienet, E.; Blanche, Séphane.; Rouzioux, C.; Avit, D.; Kruy, L.Sim.; McIntyre, J.; Say, L.; Gray, G.; Ekouévi, D.K.; Dabis, Fçois.; Arrivé, E.; Chaix, M-Laure.; Nerrienet, E.; Blanche, Séphane.; Rouzioux, C.; Avit, D.; Kruy, L.Sim.; McIntyre, J.; Say, L.; Gray, G.; Ekouévi, D.K.; Dabis, Fçois.; Dabis, Fçois.; Ekouévi, D.K.; Rouzioux, C.; Blanche, Séphane.; Treluyer, J-Marc.; Chaix, M-Laure.; Rey, E.; N'Dri-Yoman; Kruy, L.Sim.; Nerrienet, E.; Gray, G.; McIntyre, J.; Arrivé, E.; Hirt, Déborah.; Urien, S.; Pruvost, A.; Allou, Gérard.; A 2010: Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance Aids 24(16): 2481-2488
García-Lerma, J.Gerardo.; Otten, R.A.; Qari, S.H.; Jackson, E.; Cong, M-Er.; Masciotra, S.; Luo, W.; Kim, C.; Adams, D.R.; Monsour, M.; Lipscomb, J.; Johnson, J.A.; Delinsky, D.; Schinazi, R.F.; Janssen, R.; Folks, T.M.; Heneine, W. 2008: Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir Plos Medicine 5(2): E28
Pujari, S.; Dravid, A.; Gupte, N.; Joshi, K.; Bele, V. 2008: Effectiveness and safety of generic fixed-dose combination of tenofovir/emtricitabine/efavirenz in HIV-1-infected patients in Western India Medscape Journal of Medicine 10(8): 196
Todd, C.S.; Deese, J.; Wang, M.; Hubacher, D.; Steiner, M.J.; Otunga, S.; Van Damme, L. 2015: Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya Contraception 91(3): 248-252
Baeten, J.M.; Donnell, D.; Mugo, N.R.; Ndase, P.; Thomas, K.K.; Campbell, J.D.; Wangisi, J.; Tappero, J.W.; Bukusi, E.A.; Cohen, C.R.; Katabira, E.; Ronald, A.; Tumwesigye, E.; Were, E.; Fife, K.H.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Kidoguchi, L.; Coombs, R.W.; Hendrix, C.; Marzinke, M.A.; Frenkel, L.; Haberer, J.E.; Bangsberg, D.; Celum, C. 2014: Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial Lancet. Infectious Diseases 14(11): 1055-1064